[
  {
    "ts": null,
    "headline": "IQVIA Holdings (IQV) Snaps 2-Day Losses on Higher-than-Expected Earnings",
    "summary": "We recently published 10 Stocks with Surprising Gains. IQVIA Holdings Inc. (NYSE:IQV) is one of Tuesday’s top performers. IQVIA Holdings snapped a two-day losing streak on Tuesday, jumping by 17.88 percent to close at $187.38 apiece as investor sentiment was bolstered by higher-than-expected earnings performance in the second quarter of 2025. In its earnings release, IQVIA Holdings […]",
    "url": "https://finnhub.io/api/news?id=85b86c35daa5d38745ba19b866ae1bdc6533cd1d1899543cb5e3e1cbce98cff4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753294997,
      "headline": "IQVIA Holdings (IQV) Snaps 2-Day Losses on Higher-than-Expected Earnings",
      "id": 136062955,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "We recently published 10 Stocks with Surprising Gains. IQVIA Holdings Inc. (NYSE:IQV) is one of Tuesday’s top performers. IQVIA Holdings snapped a two-day losing streak on Tuesday, jumping by 17.88 percent to close at $187.38 apiece as investor sentiment was bolstered by higher-than-expected earnings performance in the second quarter of 2025. In its earnings release, IQVIA Holdings […]",
      "url": "https://finnhub.io/api/news?id=85b86c35daa5d38745ba19b866ae1bdc6533cd1d1899543cb5e3e1cbce98cff4"
    }
  },
  {
    "ts": null,
    "headline": "Why IQVIA (IQV) Stock Is Up Today",
    "summary": "Shares of clinical research company IQVIA (NYSE: IQV) jumped 3% in the afternoon session on continued positive momentum after the company reported better-than-expected second-quarter earnings and received several price target increases from Wall Street analysts.",
    "url": "https://finnhub.io/api/news?id=e6ef8e10ab178783bbf38c9a2c8c56d9ba7772c3a3567481a4e64547d3b7e2b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753291912,
      "headline": "Why IQVIA (IQV) Stock Is Up Today",
      "id": 136062956,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "Shares of clinical research company IQVIA (NYSE: IQV) jumped 3% in the afternoon session on continued positive momentum after the company reported better-than-expected second-quarter earnings and received several price target increases from Wall Street analysts.",
      "url": "https://finnhub.io/api/news?id=e6ef8e10ab178783bbf38c9a2c8c56d9ba7772c3a3567481a4e64547d3b7e2b5"
    }
  },
  {
    "ts": null,
    "headline": "Fiserv's Q2 Earnings Surpass Estimates, Revenues Increase Y/Y",
    "summary": "FI posts solid second-quarter 2025 earnings growth, which has boosted full-year EPS outlook, but revenue miss keeps the stock trailing its peers.",
    "url": "https://finnhub.io/api/news?id=30b6ad4b4e69ec1a84b6b06ba81f30fffbab34f44ed33a24b5467f1b3b062981",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753279080,
      "headline": "Fiserv's Q2 Earnings Surpass Estimates, Revenues Increase Y/Y",
      "id": 136062617,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "FI posts solid second-quarter 2025 earnings growth, which has boosted full-year EPS outlook, but revenue miss keeps the stock trailing its peers.",
      "url": "https://finnhub.io/api/news?id=30b6ad4b4e69ec1a84b6b06ba81f30fffbab34f44ed33a24b5467f1b3b062981"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market News for Jul 23, 2025",
    "summary": "Wall Street closed mixed on Tuesday as market participants were busy weighing uncertainties related to tariff rates and trade policies.",
    "url": "https://finnhub.io/api/news?id=7db831df40e7470a281d782f89831c3250a8108e24d64646c255e9646b04539f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753274220,
      "headline": "Stock Market News for Jul 23, 2025",
      "id": 136044495,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "Wall Street closed mixed on Tuesday as market participants were busy weighing uncertainties related to tariff rates and trade policies.",
      "url": "https://finnhub.io/api/news?id=7db831df40e7470a281d782f89831c3250a8108e24d64646c255e9646b04539f"
    }
  },
  {
    "ts": null,
    "headline": "IQVIA Holdings Inc (IQV) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic AI ...",
    "summary": "IQVIA Holdings Inc (IQV) surpasses $4 billion in quarterly revenue for the first time, while leveraging AI to drive growth despite a challenging market environment.",
    "url": "https://finnhub.io/api/news?id=d33dd2ef13fa3f2e90f305e24ca080d0edf5da33f261850d3365a888a9a10264",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753254534,
      "headline": "IQVIA Holdings Inc (IQV) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic AI ...",
      "id": 136039768,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "IQVIA Holdings Inc (IQV) surpasses $4 billion in quarterly revenue for the first time, while leveraging AI to drive growth despite a challenging market environment.",
      "url": "https://finnhub.io/api/news?id=d33dd2ef13fa3f2e90f305e24ca080d0edf5da33f261850d3365a888a9a10264"
    }
  },
  {
    "ts": null,
    "headline": "IQV Q2 Deep Dive: AI Initiatives and Pipeline Growth Drive Outperformance Amid Margin Pressures",
    "summary": "Clinical research company IQVIA (NYSE: IQV) announced better-than-expected revenue in Q2 CY2025, with sales up 5.3% year on year to $4.02 billion. The company’s full-year revenue guidance of $16.2 billion at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $2.81 per share was 1.4% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=5230a762b3031c74d1d32242a16c7026f02dfff513db9d08af72bdeab8eae670",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753248775,
      "headline": "IQV Q2 Deep Dive: AI Initiatives and Pipeline Growth Drive Outperformance Amid Margin Pressures",
      "id": 136039769,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "Clinical research company IQVIA (NYSE: IQV) announced better-than-expected revenue in Q2 CY2025, with sales up 5.3% year on year to $4.02 billion. The company’s full-year revenue guidance of $16.2 billion at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $2.81 per share was 1.4% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=5230a762b3031c74d1d32242a16c7026f02dfff513db9d08af72bdeab8eae670"
    }
  }
]